AGEN · NASDAQ
Agenus (AGEN) Stock Price & Fundamentals
Agenus (AGEN) closed at $354.82 on Oct 9, 2026, up 0.18% from the previous close of $354.18.
Share price, past year
1Y +2.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $354.82 |
| Sep 30, 2026 | $348.74 |
| Aug 31, 2026 | $346.74 |
| Jul 31, 2026 | $345.86 |
| Jun 30, 2026 | $335.61 |
| May 29, 2026 | $333.69 |
| Apr 30, 2026 | $347.02 |
| Mar 31, 2026 | $346.01 |
| Feb 27, 2026 | $346.09 |
| Jan 30, 2026 | $353.35 |
| Dec 31, 2025 | $352.88 |
| Nov 28, 2025 | $344.20 |
| Oct 31, 2025 | $351.57 |
Key statistics
- Market cap
- $15.12B
- P/E (TTM)
- 116.7
- EPS (TTM)
- $3.04
- Revenue (TTM)
- $132.69M
- Net income (TTM)
- —
- Shares outstanding
- 42.6M
- Dividend yield
- —
- 52-week range
- $324.04 – $368.71
Agenus's market cap is $15.12B, based on a share price of $354.82 and 42.6M shares outstanding as of Jun 30, 2026.
Financials
Agenus reported revenue of $114.20M for fiscal 2025, up 10.37% from fiscal 2024.
Agenus reported a net loss of $120.69M in fiscal 2017.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $114.20M | +10.4% | — | — | $0.00 | −$77.20M |
| FY2024ended Dec 31, 2024 | $103.46M | −33.8% | — | — | −$10.59 | −$158.89M |
| FY2023ended Dec 31, 2023 | $156.31M | +59.5% | — | — | −$13.75 | −$234.16M |
| FY2022ended Dec 31, 2022 | $98.02M | −66.9% | — | — | −$15.64 | −$228.44M |
| FY2021ended Dec 31, 2021 | $295.67M | +235.3% | — | — | −$0.11 | −$23.67M |
| FY2020ended Dec 31, 2020 | $88.17M | −41.2% | — | — | −$1.05 | −$142.56M |
| FY2019ended Dec 31, 2019 | $150.05M | +307.9% | — | — | −$0.80 | −$23.34M |
| FY2018ended Dec 31, 2018 | $36.78M | −14.2% | — | — | −$1.44 | −$134.69M |
| FY2017ended Dec 31, 2017 | $42.88M | +90.0% | −$120.69M | −281.5% | −$1.23 | −$97.35M |
| FY2016ended Dec 31, 2016 | $22.57M | — | −$127.00M | −562.6% | −$1.46 | −$92.48M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $34.52M | — | −$0.01 |
| Q1 FY2026ended Mar 31, 2026 | $33.74M | — | $1.02 |
| Q4 FY2025ended Dec 31, 2025 | $34.20M | — | $0.09 |
| Q3 FY2025ended Sep 30, 2025 | $30.24M | — | $1.94 |
| Q2 FY2025ended Jun 30, 2025 | $25.69M | — | −$1.00 |
| Q1 FY2025ended Mar 31, 2025 | $24.07M | — | −$1.03 |
| Q4 FY2024ended Dec 31, 2024 | $26.84M | — | −$1.95 |
| Q3 FY2024ended Sep 30, 2024 | $25.11M | — | −$3.08 |
Company profile
- Name
- Agenus Inc.
- Ticker
- AGEN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 3 Forbes Road, Lexington, MA 02421
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001098972
Recent SEC filings
- Aug 18, 2026
- Aug 13, 2026
- Aug 11, 2026
- Aug 7, 2026
- Aug 6, 2026
- Jul 13, 2026
- Jul 6, 2026
- Jun 23, 2026
Frequently asked questions
What is Agenus's stock price?
Agenus (AGEN) closed at $354.82 on Oct 9, 2026, up 0.18% from the previous close of $354.18.
What is Agenus's market cap?
Agenus's market cap is $15.12B, based on a share price of $354.82 and 42.6M shares outstanding as of Jun 30, 2026.
How much revenue does Agenus make?
Agenus reported revenue of $114.20M for fiscal 2025, up 10.37% from fiscal 2024.
What is AGEN's P/E ratio?
Agenus's price-to-earnings ratio is 116.7, based on trailing twelve-month diluted EPS of $3.04.
Does Agenus pay a dividend?
Agenus's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Agenus Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures